Abstract
Ocular Toxic Effects of Fenretinide
Highlights
(2) KERR R, PIPPEN P, MENNEL R, ET AL: Treatment of metastatic malignant melanoma with a combination of interferon alpha-2a (Ifn alpha2a; Roferon) and dacarbazine (DTIC)
Proc ASCO 8:284, 1989 (4) KIRKWOOD JM, ERNSTOFFMS: Potential applications of the interferons in oncology: Lessons drawn from studies of human melanoma
Fenretinide was inactive in advanced disease, its toxic effects were mild and reversible
Summary
(/) BAJETTA E, NEGRETTI E, GIANNOTTI B, ET AL: Phase II study of interferon alpha-2a (rIFN alpha-2a) and dacarbazine (DTIC) in metastatic melanoma (MM). Proc ASCO 8:286, 1989 (2) KERR R, PIPPEN P, MENNEL R, ET AL: Treatment of metastatic malignant melanoma with a combination of interferon alpha-2a (Ifn alpha2a; Roferon) and dacarbazine (DTIC). Versus DTIC and recombinant interferon alfa 2b (rIFNa 2b) in the treatment of patients (PTS) with advanced malignant melanoma (MM). Proc ASCO 8:284, 1989 (4) KIRKWOOD JM, ERNSTOFFMS: Potential applications of the interferons in oncology: Lessons drawn from studies of human melanoma.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
